Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Biopharmaceuticals Companies

Biopharmaceuticals, also known as biologics, are medical products derived from biological sources, such as living organisms or their components. These products are widely used in the treatment and prevention of various diseases and medical conditions. Numerous companies specialize in the research, development, and manufacturing of biopharmaceuticals.

Biopharmaceuticals Key Companies

Latest Biopharmaceuticals Companies Update

Bristol Myers Squibb Acquires Turning Point Therapeutics: This USD 3.4 billion deal bolsters Bristol Myers Squibb's oncology pipeline with Turning Point's TP-5992, a promising drug candidate for solid tumors.

AbbVie Snaps Up Teneobio: This USD 1.6 billion acquisition strengthens AbbVie's immunology portfolio with Teneobio's TNX-102, a potential treatment for inflammatory bowel disease.

Regeneron Receives FDA Approval for Dupixent to Treat Eosinophilic Esophagitis: This expands the reach of Dupixent, a blockbuster drug already approved for asthma, eczema, and other allergic conditions.

AstraZeneca's Imfinzi Wins FDA Approval for Extensive-Stage Small Cell Lung Cancer: This marks a significant milestone in the treatment of this aggressive cancer, offering a new option for patients.

List of Biopharmaceuticals Key companies in the market

Pfizer, Inc. (US)

Amgen Inc. (US)

Eli Lilly and Company (US)

Hoffmann-La Roche Ltd (Switzerland)

Johnson & Johnson (US)

Gilead Sciences, Inc. (US)

AstraZeneca (UK)

Abbvie Inc. (US)

Sanofi (France)

Bristol-Myers Squibb Company (US)

Sandoz International GmbH (Germany)

Novo Nordisk A/S (Denmark)

GlaxoSmithKline PLC (UK)

Merck KGaA (Germany)

Biocon (India)

Biopharmaceuticals Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.